NCT05152940View on ClinicalTrials.gov

ERTU-SODIUM: Study on the Effects of Ertugliflozin on Sodium Storage, Interstitial Volume, and Plasma Volume in HFrEF

PHASE4RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Heart Failure With Reduced Ejection FractionCongestion
Interventions
DRUG

Ertugliflozin

Treatment with Ertugliflozin 5 mg oral once per day for one month

DRUG

Placebo

Treatment with matching placebo to ertugliflozin administered orally once daily for a period of one month

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER